Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 45 Uterine Cervical Neoplasms 10 Melanoma 10 Endometrial Neoplasms 9 Mouth Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Carcinoma, Intraductal, Noninfiltrating 4 Vulvar Neoplasms 3 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Uterine Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Micrometastasis 2 Neoplasm Metastasis 2 Lymphatic Metastasis 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Eccrine Porocarcinoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Breast Carcinoma In Situ 2 Anus Neoplasms 2 Waldenstrom Macroglobulinemia 1 Sentinel Lymph Node Biopsy (SLNB) 1 Sentinel Lymph Node 1 Sarcoidosis, Pulmonary 1 Sarcoidosis 1 Rhabdomyosarcoma 1 Recurrence 1

Interventions

Cyclophosphamide 155 Dexamethasone 141 Rituximab 85 fludarabine 80 Lenalidomide 72 Cytarabine 70 Bortezomib 65 fludarabine phosphate 63 Gemcitabine 62 venetoclax 55 pomalidomide 53 Etoposide 53 pembrolizumab 52 Paclitaxel 48 Cisplatin 48 Carboplatin 48 Peripheral Blood Stem Cell Transplantation 47 Filgrastim 40 Radiotherapy 39 Busulfan 37 Calcium Dobesilate 36 Methotrexate 34 Melphalan 34 Bevacizumab 33 carfilzomib 32 Cyclosporine 32 Azacitidine 32 Mycophenolic Acid 30 Vincristine 29 Bendamustine Hydrochloride 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Sentinel Lymph Node Biopsy × Clear all

NCT03719547 2025-07-01

RACC

Karolinska Institutet

Phase NA Recruiting

Uterine Cervical Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡